Georgia as a Biotechnology Capital?

Thursday, April 14, 2016
9:00 a.m.-1:30 p.m.
Emory Conference Center Hotel, Starvine Ballroom
1615 Clifton Road NE
Atlanta, GA 30329

Keynote Speakers

C. Michael Cassidy, President and Chief Executive Officer, Georgia Research Alliance (GRA)
READ NOW: Looking Back: Moving Forward – Defining Moments in Building Georgia’s Biotech Prominence

Cassidy will provide a local state-of-affairs on Georgia’s biotechnology past, present, and future to begin open dialogue and motivate change. As the leader of GRA for 16 years, he will deliver clear insight on the state’s journey as a biotechnology capital. While sharing his vision for the state, celebrating our strengths, and defining our weaknesses. His experience and understanding of city and state politics will resonate and enlighten the expert audience.

Kenneth I. Moch, Managing Partner, Salutramed Group
Building Georgia's Biotech Cluster - A National Perspective

Moch will offer a regional and national perspective and discuss the current and future biotechnology climate. He will share best practices and advice for Georgia to become a biotechnology capital using his broad expertise building, managing, and financing private and public life sciences companies from start-up through commercialization, and creation of five companies which have pioneered novel technologies.

What is the purpose?

The Atlanta Clinical & Translational Science Institute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state's life sciences industry association, organizes this conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. The event provides a collaborative environment for university investigators and industry executives using a program filled with subject matter experts describing current models and innovative trends shaping the future of translational science.

What will be discussed?

The Seventh Annual Academic & Industry Intersection Conference explored Georgia’s biotechnology climate, venture capital innovation, and featured an expert panel highlighting commercialization training options throughout the state.

Contact

Elizabeth Pittman Thompson

Upcoming Events

View All Events

Discovery News

Training

KL2 Scholar Studies Novel Hematopoietic Stem Cell Approach to Sickle Cell Disease Treatment

Elizabeth Stenger, MD, MSc, assistant professor, Department of Pediatrics, Emory University School of Medicine, received a K23 award for her work on improving haploidentical hematopoietic stem cell transplantation in sickle cell disease using...

Discovery

Research Resources 101: Using ACTSI's i2b2 Tool to Query Electronic Healthcare Records for Patient Study Feasibility Data-Thursday

The capabilities of Emory i2b2 will be discussed including how to query the Emory Healthcare electronic health record data for patient counts and aggregate data for grants/IRB protocols and other ways i2b2 can accelerate the pre-research process....